We aim to study the interplay between TLSs and tumor stroma blood vessels (immature-CD34+/SMA−, versus mature-CD34+/SMA+), to find if this interrelation is BC subtype-specific and may influence lymphovascular and perineurial invasion and recurrence. This evidence concerns the gene CD34 and neoplasm.